Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Anakinra/canakinumab

Various toxicities: 19 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Babaoglu H, et al. Effectiveness of canakinumab in colchicine- and anakinra-resistant or -intolerant adult familial mediterranean fever patients: A single-center real-life study. JCR: Journal of Clinical Rheumatology 26: 7-13, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1097/RHU.0000000000000873

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Anakinra/canakinumab. Reactions Weekly 1791, 27 (2020). https://doi.org/10.1007/s40278-020-74872-3

    Download citation